tirzepatide label template Peptide Templates Tirzepatide 100mg Kit – 10×10mg

Digestive history matters

Findings: RCTSURMOUNT-MAINTAIN - Tirzepatide for Maintenance of Bodyweight Reduction in Obesity, Lancet (2026) [PubMed abstract] Design: Randomized, placebo-controlled trial (N=378 | length = 112 weeks) in adults with obesity who completed 60 weeks of open-label tirzepatide at the maximum tolerated dose (10 or 15 mg once weekly) Treatment: Continue tirzepatide maximum tolerated dose (MTD

Massa magra non significa automaticamente muscolo perso Quando si analizza la composizione corporea con strumenti come: la massa magra comprende: Per questo motivo, una riduzione della lean mass non equivale sempre a una perdita reale di tessuto muscolare contrattile

Monitor the scale weekly

Both medications can cause side effects such as nausea, vomiting, diarrhea, and constipation, and are typically given as once-weekly injections

They're comparable, mostly mild, short-lived GI effects such as nausea, since both act on related pathways